Nutritional, Metabolic, Endocrine
Conditions
Interventions
intervention group
Control Group
Sponsors
Antenna Foundation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Type 2 diabetes patients with poorly controlled glycaemia, despite =6 months usual care (lifestyle + medication if applicable) + at least one of the following measurements: - Fasting plasma glucose (FPG) values > 7.0 mmol/L (126 mg/dl), - or 2-h post-load plasma glucose > 11.1 mmol/L (200 mg/dl), - or HbA1c > 6.5% (48 mmol/mol); - or a random blood glucose > 11.1 mmol/L (200 mg/ dl) . - If under medication, it has been remaining the same treatment and dosage for at least 3 months -- and it is planned to keep this treatment the same for the next 3 months
Exclusion criteria
Exclusion criteria: - All severe complications of diabetes: end-organ damage such as nephropathy, retinopathy, neuropathy, etc... - Any health condition that requires urgent attention - Patients with a cognitive or sensory impairment that may prevent conducting the interview
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Percentage of patients in each group reaching a decrease of = 0.5mmol/L in FPG - Percentage of patients reaching a decrease of = 0.5 points of percentage from the baseline value in HbA1c; each of these reductions being deemed as clinically significant. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Mean reduction of FPG and mean reduction of HbA1c e.g. differences between baseline values and values at 3 months; - Proportion of patient in each group reaching target glycaemia (<7mmol/L for FPG and <6,5% for HbA1c); - Mean change of weight and mean change of blood pressure e.g. differences between baseline values and values at 3 months; - Proportion of patients who wish to continue to take the plant after the intervention; - Assessment of adverse effects. | — |
Countries
Ethiopia
Contacts
Public ContactAbyot Endale
Head of the School of the Pharmacy
Outcome results
None listed